5 Tips to Get Ready for the New EU In-Vitro Diagnostic Device Regulation

By end of 1998, the first European quality and safety requirements for in vitro diagnostic medical...

Read More
Well-being Through Bike to Work — 2019 Results Are In!

Time: 6.40 am.

The tires make a tiny screech when hitting the asphalt. The helmet is on and the...

Read More
7 Smart Ways to Prevent Diagnostics System Development Projects from Failing

Diagnostic system development projects can be more prone to failure than you would think. Despite...

Read More
Expert Interview — How to Combine Biology and Engineering into Marketable Solutions

Laboratory automation development is a field best characterized by its interdisciplinarity. In...

Read More
HSE•AG will be at SLAS Barcelona, 26-28 June 2019!

We're glad to announce that HSE will be attending the SLAS Europe 2019 Conference in Barcelona!


Read More

Day 5: Final impressions of J.P. Morgan Healthcare Conference

The 36th annual J.P. Morgan Healthcare Conference in San Francisco drew to a close with many discussions focused on commercialization of technologies and investment opportunities.

As mentioned in a previous post, it is now crystal clear why the annual J.P. Morgan Healthcare Conference is often referred to as the Superbowl of biotech. For example, over 1,000 attendees stood in line Monday for around 45 minutes to secure a coveted place at Bill Gate’s keynote speech.

The J.P. Morgan Healthcare Conference kicked off Monday with presentations from some of the giants in the life science and molecular diagnostics industries, such as Genomic Health, Foundation Medicine, QIAGEN, Myriad Genetics, Guardant, 10x Genomics, Twist Bioscience, Bruker, etc, which set the pace for the rest of the week. The high standard continued on Tuesday and Wednesday with presentations from more companies in the life science and diagnostic industries as well as lab operators: LabCorp, DiaSorin, Danaher, Exact Sciences, Hologic, Quest Diagnostics, Invitae, PerkinElmer, Quidel, Konica Minolta, GenMark, and more. More information on the presentations is available from genomeweb: https://www.genomeweb.com/business-news

The last day of the 36th annual J.P. Morgan Healthcare Conference ended with an invitation from the Haas Healthcare Association (HHA) and Berkeley Center for Health Technology (BCHT) to the 2nd annual Alumni Mixer happy hour. This event brings students and alumni together and gives them the opportunity to network and make new contacts.

HSE•AG has had numerous opportunities over the last few days to meet many professionals from the life science and molecular diagnostics industries and to expand their business network. Once again, attending the J.P. Morgan Healthcare Conference is an invaluable experience for all companies in the industry and definitely for us.

This is our last blog post from the J.P. Morgan Healthcare Conference. Please click on the button below to read the other blog posts. 

All Articles

Posted by Patrick Widler


HSE•AG specializes in turning ideas into cutting-edge solutions and in successfully bringing them to market. Their broad knowledge in laboratory automation development is complemented by extensive experience in industrialization, life cycle management, project management, OEM modules, and consulting – offering their clients an all-in-one partnership.